Tag: TLRY

INO Update & More

Inovio Pharmaceuticals, Inc. INO 

We signaled INO on Thursday morning, and this week, the stock has enjoyed some really solid activity, which facilitated the chance at a big gain for traders. We have observed a range of 3.83-7.48 in just a couple of sessions. That works out to total potential profit of 95%

It was a buck of the overall trend as many of these pharma plays have been doing through the coronavirus scare currently in progress. While the markets got a momentary boost from the Fed’s surprise rate cut yesterday, it was not long-lived, and the decline for other stocks continued throughout the majority of the session.

This morning, the stock has hit 8.80 in the premarket, extending our observed gain this week to 130%

While world governments rush to contain the spread of the virus, it would not yet be accurate to call it under control. We would expect much more hardship on the day-to-day for stocks before we’re out of the woods. So plays like INO are a welcome respite during this tumultuous time, and we’ll do our best to keep them coming.

Fresh Options Ideas 
CPB Weekly $49-50.50 Calls
JWN Weekly $32.50-30 Puts

Extended Watchlist:
LLIT, NVNT, SPOM, TLRY, TOMZ

2019 Winners That Could Keep Running in 2020

FuelCell Energy, Inc. FCEL

For our first mention of the year, we are looking at FCEL, which ended up registering as the NASDAQ’s #1 daily gainer on New Year’s Eve. We’ve been tagging this one amid its recent push to new highs, but we actually began our coverage in October. (We always have receipts! You can view all of our reports containing a mention of this stock by clicking here.) The stock established its bottom shortly thereafter on Halloween, when it registered a low of .23.

FCEL had a productive fall and early winter, and on Tuesday, pushed to a brand new high of 2.75. That’s an unbelievable increase of 1096% in exactly two months’ time. Even if you only caught our more recent December 20th alert on FCEL  after which the PPS low was .71, Tuesday’s high enabled gains of up to 272%

It was a great call to close out 2019, and we’re ready to tackle 2020 head-on! We won’t rule out the possibility of FCEL continuing its incredible uptrend, in fact, the stock has set another new high of 2.95 here in the premarket so far!

Other New Highs 

We recently brought up ONCY and OWCP for their solid performances after we had placed them on watch, and both finished out 2019 by recording new highs as well!

Oncolytics Biotech, Inc. ONCY was coincidentally tagged in the same November report as FCEL, as well as several more recent mentions, if you check the tag in our archives. Just a couple of days following that November alert, ONCY saw a low of .82. On Tuesday its new high came in at 6.02, for a whopping gain of 634%
____

As for OWC Pharmaceutical Research Corp. OWCP, on Tuesday morning we were just heralding the spectacular progress it has made since our initial call at .028, and the stock once again made a multibag intraday surge to new highs to close out the year, hitting .09, and registering as an increase of 221%

Fresh Options Idea:
RAD 01/10 $16.50-18 Calls 

Extended Watchlist:
TLRY, CGC, CRON, GEVO, SAVA, AKCA, AKRX (Bottom bouncer)

Blue Horseshoe Stocks: TLRY Recap & More


Tilray, Inc. TLRY

Our first order of business this morning is to just provide a quick recap of our successful options idea from Friday, which we did not provide yesterday due to the release of our Special Report on PASO.(Check that report out if you missed it)

In Friday’s newsletter, we submitted the TLRY Weekly $92.50-95 Calls as potential day-trade candidates, and every single contract in that range provided huge multi-bag gain opportunities!

$92.50 Calls – Range: 2.10-8.30 – Max Gain: 295%
$93 Calls – Range: 2.00-9.20 – Max Gain: 360%
$93.50 Calls – Range: 1.80-5.00 – Max Gain: 178%
$94 Calls – Range: 2.14-9.83 – Max Gain: 359%
$95 Calls – Range: 1.21-8.85 – Max Gain: 631%

OPKO Health, Inc. OPK – Review

The last time we signaled OPK for observation was just a few weeks ago, on December 28th, just as the stock was gapping up off of its annual lows. Following that report, we’ve seen a couple weeks of steady gains, in an overall range from 2.84-3.935. That represents a solid 39% increase, and a good start to the 2019 calendar year.

We’ve also observed CEO Phillip Frost purchasing 15,000 shares out of the open market yesterday, near those highs. The next step for OPK would be to make a run at its 200DMA of 4.12, so we’ll continue to keep it on our radar in the days and weeks ahead.

Extended Watchlist:
PASO, DTEA, FTNW, KTOV, CVM